Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

1,661 public trials 325 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Recruiting

Collection of Tissue Samples for Cancer Research

NCT00900198

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +18 more
Locations
  • UC Davis Sacramento, California, United States
  • University of Colorado, Denver Aurora, Colorado, United States
  • Emory University Atlanta, Georgia, United States
  • Indiana University - Purdue Indianapolis, Indiana, United States
View all 17 locations
View Trial Details
Recruiting

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

NCT02693535

Conditions
Advanced Solid Tumors, Blood Protein Disorders, Cardiovascular Diseases, +16 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Cancer Treatment Centers of America-Phoenix Phoenix, Arizona, United States
  • Sutter Auburn Auburn, California, United States
  • Sutter Alta Bates Berkeley, California, United States
View all 181 locations
View Trial Details
Recruiting

A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma

NCT06988488

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Yale New Haven Hospital-Smilow Cancer Center New Haven, Connecticut, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
View all 22 locations
View Trial Details
Recruiting

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

NCT06297226

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • UCLA Hematology/Oncology - Westwood (Building 200 Suite 214) Los Angeles, California, United States
View all 52 locations
View Trial Details
Recruiting

A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy

NCT07249528

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Consent Only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent Only) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Consent Only) Commack, New York, United States
View Trial Details
Recruiting

A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

NCT07409246

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • City of Hope National Medical Center /ID# 280273 Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 279067 Irvine, California, United States
  • Colorado Blood Cancer Institute /ID# 280275 Denver, Colorado, United States
  • City Of Hope - Atlanta. /ID# 280294 Newnan, Georgia, United States
View Trial Details
Recruiting

Combination Treatment of Belantamab Mafodotin and Venetoclax in Treatment of Relapsed and Refractory t(11;14) Multiple Myeloma

NCT05853965

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • University Medical Center Hamburg-Eppendorf Hamburg, Ham, Germany
  • Klinikum Chemnitz Chemnitz, Germany
  • Uniklinik Heidelberg Heidelberg, Germany
  • UKSH Lübeck Lübeck, Germany
View Trial Details
Recruiting

A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

NCT05828511

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of California Los Angeles (UCLA) Los Angeles, California, United States
  • UC Irvine Health Orange, California, United States
  • Colorado Blood Cancer Institute/SCRI Denver, Colorado, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
View all 32 locations
View Trial Details

Related conditions